Marjukka Anttila

8PUBLICATIONS
28CO-AUTHORS
Veterinary diagnosis and diagnosticsMolecular targetsAnimal growth and developmentCancer therapy (excl. chemotherapy and radiation therapy)Animal structure and function
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 10, 2024
Local and Systemic Inflammation in Finnish Dairy Cows with Digital Dermatitis.

Hertta Pirkkalainen, Aino Riihimäki, Taru Lienemann

|Nov 10, 2023
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer.

D C A Quixabeira, S Pakola, E Jirovec

|Sep 04, 2023
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine.

D C A Quixabeira, E Jirovec, S Pakola

|Jan 27, 2022
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1.

Dafne C A Quixabeira, Victor Cervera-Carrascon, Joao M Santos

|Apr 09, 2021
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration.

Marjo K Hytönen, Riika Sarviaho, Christopher B Jackson

|Jan 30, 2021
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1.

Riikka Havunen, Riikka Kalliokoski, Mikko Siurala

Pageof 2

Frequent Collaborators

3 joint publications

Dafne C A Quixabeira

3 joint publications

Tatiana V Kudling

3 joint publications

Akseli Hemminki

2 joint publications

S Pakola